Absence of measles virus genome and transcripts in Hodgkin-Reed/Sternberg cells of a cohort of Hodgkin lymphoma patients

International Journal of Cancer

Volumn 121, Issue 2, 2007, Pages 448-453

  Maggio, Ewerton ^a   Benharroch, Daniel ^b   Gopas, Jacob ^b,c   Dittmer, Ulf ^a   Hansmann, Martin Leo ^d   Küppers, Ralf ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Hodgkin lymphoma; Measles; Pathogenesis; Virus

Indexed keywords

HEMAGGLUTININ; MATRIX PROTEIN; NUCLEOPROTEIN; VIRUS RNA;

ARTICLE; CELL LINE; COHORT ANALYSIS; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GERMANY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISRAEL; MEASLES VIRUS; MICRODISSECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REED STERNBERG CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION;

CELL LINE, TUMOR; COHORT STUDIES; GENOME, VIRAL; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MEASLES; MEASLES VIRUS; REED-STERNBERG CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

EID: 34250307600     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22628     Document Type: Article

References (42)

1. Küppers R. Molecular biology of Hodgkin's lymphoma. Adv Cancer Res 2002;84:277-312.
2. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dörken B. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100:2961-9.
3. Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT. Mutations in the IκBα gene in Hodgkin's disease suggest a tumour suppressor role for IκBα. Oncogene 1999;18:3063-70.
4. Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, Mathas S, Krappmann D, Scheidereit C, Stein H, Dörken B. Overexpression of IκBα without inhibition of NF-κB activity and mutations in the IκBα gene in Reed-Sternberg cells. Blood 1999;94:3129-34.
5. Jungnickel B, Staratschek-Jox A, Bräuninger A, Spieker T, Wolf J, Diehl V, Hansmann ML, Rajewsky K, Küppers R. Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 2000;191:395-402.
6. Joos S, Kupper M, Ohl S, von Bonin F, Mechtersheimer G, Bentz M, Marynen P, Möller P, Pfreundschuh M, Trümper L, Lichter P. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 2000;60:549-52.
7. Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G, Parwaresch RM, Lichter P, Siebert R, Möller P. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood 2003;101:3681-6.
8. Weniger MA, Melzner I, Menz CK, Wegener S, Bucur AJ, Dorsch K, Mattfeldt T, Barth TF, Möller P. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 2006;25:2679-84.
9. Jarrett RF, MacKenzie J. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease. Semin Haematol 1999;36:260-9.
10. Küppers R. B cells under influence: Transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 2003;3:801-12.
11. Gutensohn N, Cole P. Epidemiology of Hodgkin's disease in the young. Int J Cancer 1977;19:595-604.
12. Armstrong AA, Shield L, Gallagher A, Jarrett RF. Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease. Br. J Cancer 1998;77:1045-7.
13. Gallagher A, Perry J, Shield L, Freeland J, MacKenzie J, Jarrett RF. Viruses and Hodgkin disease: no evidence of novel herpesviruses in non-EBV-associated lesions. Int J Cancer 2002;101:259-64.
14. Benharroch D, Shemer-Avni Y, Levy A, Myint YY, Ariad S, Rager B, Sacks M, Gopas J. New candidate virus in association with Hodgkin's disease. Leuk Lymphoma 2003;44:605-10.
15. Benharroch D, Shemer-Avni Y, Myint YY, Levy A, Mejirovsky E, Suprun I, Shendler Y, Prinsloo I.,Ariad S, Rager-Zisman B, Sacks M, Gopas J. Measles virus: evidence of an association with Hodgkin's disease. Br J Cancer 2004;91:572-9.
16. Griffin DE. Measles virus. In: Knipe DM, Howley PM, eds. Fields virology. 4th edn. Philadelphia: Lippincolt. Williams and Wilkins. 2001. 1401-41.
17. Rima BK. Molecular mechanisms of measles virus persistence. Virus Res 2005;111:132-47.
18. Burnstein T, Jacobsen LB, Zeman W, Chen TT. Persistent infection of BSC-I cells by defective measles virus derived from subacute sclerosing panencephalytis. Infect Immun 1974;10:1378-82.
19. Gould EA, Linton PE. The production of temperature sensitive persistent measles virus infection. J Gen Virol 1975;28:21-8.
20. Cremer NE, Oshiro LS, Hagens SJ. Cyclic expression of antigen and infectious virus in a BHK cell line (0-853) persistently infected with an SSPE strain of Measles virus. J Gen Virol 1979;42:637-40.
21. Koschel K, Münzel P. Persistent paramyxovirus infections and behavior of beta-adrenergic receptors in C-6 rat glioma cells. J Gen Virol 1980;47:513-7.
22. Kis LL, Nagy N, Klein G, Klein E. Expression of SH2DIA in live classical Hodgkin's disease-derived cell lines. Int J Cancer 2003;104:658-61.
23. Schwering I, Bräuninger A, Distler V, Jesdinsky J, Diehl V, Hansmann ML, Rajewsky K, Küppers R. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes. Mol Med 2003;9:85-95.
24. Niedobitek G, Young LS, Lau R. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a delectable latent phase. J Gen Virol 1991;72:3035-46.
25. Kanzler H, Küppers R, Helmes S, Wacker HH, Chott A, Hansmann ML, Rajewsky K. Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-centre B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 2000;95:1023-31.
26. Afzal MA, Armitage E, Begley J, Bentley ML, Minor PD., Ghosh S, Ferguson A. Absence of detectable measles virus genome sequence in inflammatory bowel disease tissues and peripheral blood lymphocytes. J Med Virol 1998;55:243-9.
27. Afzal MA, Armitage E, Ghosh S, Williams LC, Minor PD. Further evidence of the absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease. J Med Virol 2000;62:377-82.
28. Afzal MA, Osterhaus AD, Cosby SL, Jin L, Beeler J, Takeuchi K, Kawashima H. Comparative evaluation of measles virus-specific RT-PCR methods through an international collaborative study. J Med Virol 2003;70:171-6.
29. Schneider-Schaulies S, Liebert UG, Segev Y, Rager-Zisman B, Wolfson M, ter Meulen V. Antibody-dependent transcriptional regulation of measles virus in persistently infected neural cells. J Virol 1992;66:5534-41.
30. Rima BK, Earle JA, Baczko K, ter Meulen V, Liebert UG, Carstens C, Carabana J, Caballero M, Celma ML., Fernandez-Munoz R. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol 1997;78:97-106.
31. Van den Berg A, Visser L, Poppema S. High expression of the CC chemokine IARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am J Pathol 1999;154:1685-91.
32. Taqi AM, Abdurrahman MB, Yakubu AM, Fleming AF. Regression of Hodgkin's disease after measles. Lancet 1981:;16:1112.
33. Schattner A. Therapeutic role of measles vaccine in Hodgkin's disease. Lancet 1984;21:171.
34. Montella M, Maso LD, Crispo A, Talamini R, Bidoli E, Grimaldi M, Giudice A, Pinto A, Franceschi S. Do childhood diseases affect NHL and HL risk? A case-control study from Northern and Southern Italy. Leuk Res 2006;30:917-22.
35. Nyari TA, Dickinson HO, Hammal DM, Parker L. Childhood solid tumours in relation to population mixing around the time of birth. Br J Cancer 2003;88:1370-4.
36. Chadwick N, Bruce I, Davies M, van Gemen B, Schukkink R, Khan K, Pounder R, Wakefield A. A sensitive and robust method for measles RNA detection. J Virol Methods 1998;70:59-70.
37. Andzhaparidze OG, Chaplygina NM, Bogomolova NN, Lone VD, Koptyaeva IB, Boriskin YuS. Non-infectious morphologically altered nucleocapsids of measles virus from persistently infected cells. Arch Virol 1987;95:17-28.
38. Mover SA, Baker SC, Horikami SM. Host cell proteins required for measles virus reproduction. J Gen Virol 1990;71:775-83.
39. Küppers R, Klein U, Schwering I, Distler V, Brauninger A, Cattoretti G, Tu Y, Stolovitzky GA., Califano A, Hansmann ML, Dalla-Favera R. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 2003:111:529-37.
40. Garbuglia AR, Iczzi T, Capobianchi MR, Pignoloni P, Pulsoni A, Sourdis J, Pescarmona E, Vilolo D, Mandelli F. Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease. and its association with EBV infection. Int J Immunopathol Pharmacol 2003;16:109-18.
41. Jelcic I, Hotz-Wagenblatt A, Hunziker A, Zur Hausen H, de Villiers EM. Isolation of multiple TT virus genotypes from spleen biopsy tissue from a Hodgkin's disease patient: genome reorganization and diversity in the hypervariable region. J Virol 2004;78:7498-507.
42. Zur Hausen H, de Villiers EM. Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas. Int J Cancer 2005;115:1-5.